Candel Therapeutics (CADL) Shares Outstanding (Diluted Average): 2021-2023
Historic Shares Outstanding (Diluted Average) for Candel Therapeutics (CADL) over the last 3 years, with Sep 2023 value amounting to $28.9 million.
- Candel Therapeutics' Shares Outstanding (Diluted Average) rose 0.10% to $28.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $28.9 million, marking a year-over-year increase of 0.10%. This contributed to the annual value of $28.8 million for FY2022, which is 52.72% up from last year.
- As of Q3 2023, Candel Therapeutics' Shares Outstanding (Diluted Average) stood at $28.9 million, which was down 0.00% from $28.9 million recorded in Q2 2023.
- Candel Therapeutics' 5-year Shares Outstanding (Diluted Average) high stood at $28.9 million for Q1 2023, and its period low was $11.7 million during Q2 2021.
- In the last 3 years, Candel Therapeutics' Shares Outstanding (Diluted Average) had a median value of $28.8 million in 2022 and averaged $25.6 million.
- Data for Candel Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY surged of 145.81% (in 2022) over the last 5 years.
- Quarterly analysis of 3 years shows Candel Therapeutics' Shares Outstanding (Diluted Average) stood at $18.9 million in 2021, then soared by 52.72% to $28.8 million in 2022, then increased by 0.10% to $28.9 million in 2023.
- Its Shares Outstanding (Diluted Average) stands at $28.9 million for Q3 2023, versus $28.9 million for Q2 2023 and $28.9 million for Q1 2023.